Kevin Thomas Ferro

Kevin Thomas Ferro

Vorstandsvorsitzender bei
Ferro Holdings LLC (New York)
55 Jahre
Health Technology
Finance
Consumer Services

Profil

Mr. Kevin T.
Ferro is a Chief Executive Officer at Ferro Holdings LLC (New York), a Founder, Chief Executive Officer at Vatera Healthcare Partners, a Chairman at Arisaph Pharmaceuticals, Inc. and a Chairman at ImmusanT, Inc. He is on the Board of Directors at Ekteino Laboratories, Inc. Mr. Ferro was previously employed as an Independent Director by Greenhill & Co., Inc., a Chairman by Melinta Therapeutics, Inc., a Chairman by Pearl Therapeutics, Inc., a Chief Executive & Investment Officer by Oikos Holdings LLC, a Chief Executive Officer & Investment Officer by Ferro Capital LLC, a Global Head-Alternative Investment Strategies by Commerzbank AG, and a Vice President by D.
E.
Shaw & Co. LP.
He also served on the board at KOS Pharmaceuticals, Inc., Eltrak SA and Melinta Subsidiary Corp.
He received his undergraduate degree from Harvard University.

Aktive Positionen von Kevin Thomas Ferro

UnternehmenPositionBeginn
Vorsitzender 01.01.2005
Vorsitzender -
Direktor/Vorstandsmitglied -
Vorstandsvorsitzender 01.08.2019

Ehemalige bekannte Positionen von Kevin Thomas Ferro

UnternehmenPositionEnde
GREENHILL & CO., INC. Direktor/Vorstandsmitglied 30.11.2023
MELINTA THERAPEUTICS, INC. Vorsitzender 05.08.2019
Vorstandsvorsitzender 31.12.2018
Vorsitzender 01.06.2013
Direktor/Vorstandsmitglied -
Sehen Sie sich die Erfahrung von Kevin Thomas Ferro im Detail an

Ausbildung von Kevin Thomas Ferro

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

65

Beziehungen ersten Grades

15

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen15

Health Technology

Finance

Health Technology

Finance

Consumer Services

Distribution Services

Finance

Health Technology

Finance

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

  1. Börse
  2. Insiders
  3. Kevin Thomas Ferro